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Tubulointerstitial nephritis is a cardinal renal manifestation in
leptospirosis and LipL32, the major lipoprotein component of
leptospiral outer membrane proteins (OMPs), induces a
robust inflammatory response in cultured renal proximal
tubule cells through a nuclear factor-jB-related pathway.
Here, we investigated whether Toll-like receptor (TLR), known
to play a pivotal role in innate immunity, could mediate the
inflammatory response induced by leptospiral OMPs in renal
proximal tubule cells. TLR expression was analyzed by flow
cytometry and indirect immunofluorescence in cultured
mouse proximal tubule (pyruvate kinase simian virus
40-proximal straight (PKSV-PR)) cells. Reverse
transcription-competitive polymerase chain reaction and
enzyme-linked immunosorbent assay were undertaken to
analyze the inducible effects of inducible nitric oxide
synthase (iNOS) and monocyte chemoattractant protein-1
(MCP-1 also termed CCL2) by pathogenic and
non-pathogenic leptospiral OMPs and recombinant
lipoproteins in either PKSV-PR cells or TLR-transfected human
embryonic kidney (HEK) 293 cells. Anti-TLR antibodies were
used for blocking experiments. Leptospira santarosai serovar
Shermani OMPs and LipL32 induced a significant increase in
TLR2 but not TLR4 expression in PKSV-PR cells. The increase
in iNOS and CCL2/MCP-1 mRNA expressions could be
prevented by an anti-TLR2 antibody, but not by an anti-TLR4
antibody. Furthermore, leptospiral OMPs stimulated both
CCL2/MCP-1 mRNA and secreted protein in transfected HEK
293 cells with a TLR2-expressing plasmid, but had no effect in
cells with a TLR4-expressing plasmid. In conclusion, these
findings indicate that the stimulation of iNOS and
CCL2/MCP-1 caused by pathogenic leptospiral OMPs, in
particular LipL32, in proximal tubule cells requires TLR2 for
the early inflammatory response.
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Leptospirosis is a re-emerging and widespread zoonosis in
many tropical regions.1,2 In the infected host, pathogenic
leptospires can disseminate hematogeneously and invade
kidneys, which represents one of the most frequently affected
organs, and through the effects of leptospiral endotoxins and
immunologic responses favor the development of tubulo-
interstitial nephritis.2–4
Leptospiral outer membrane proteins (OMPs) and
lipopolysaccharide (LPS) are the major antigens that confer
immunity to leptospires and are thought to be involved in
host–pathogen interactions.5 We have previously shown that
pathogenic leptospiral OMPs activate the expression of
proinflammatory genes related to tubulointerstitial nephritis
in mouse renal medullary thick ascending limb cells.6 We
have also shown that LipL32, the major leptospiral outer
membrane lipoprotein, can induce a robust inflammatory
response in cultured mouse renal proximal tubule cells.7 The
identification of virulent OMP components have represented
an important step in the understanding of the pathogenesis
of leptospirosis tubulointerstitial nephritis.4,8
Microbial invasion of the host triggers a series of events
designed to control and eventually eliminate the infection. A
number of pattern recognition receptors, which recognize
defined conserved microbial structures or products of
microbial metabolism, have been shown to play a key role
in innate immunity. Among them, the family of Toll-like
receptors (TLRs) participate in the innate defense against a
variety of bacterial infections by initiating acute inflamma-
tory responses.9,10 Recent studies have also shown that renal
tubule cells express TLRs,11 mainly TLR2 and TLR4, that are
upregulated following the reperfusion of ischemic kidneys.12
TLR4 recognizes LPS of Gram-negative bacteria,13 whereas
TLR2 provides responsiveness to bacterial lipoproteins and
peptidoglycan of Gram-positive bacteria.14–16 Recognition of
bacterial components by their respective TLRs will allow the
activation of the nuclear factor-kB pathway and the
stimulation of chemokines and cytokines production.17
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Although leptospirosis is an important cause of acute renal
failure, the mechanism of renal dysfunction caused by this
microorganism is not fully understood. We have shown that
leptospiral OMPs and the main antigenic component, LipL32
lipoprotein, certainly play a role in the pathogenesis of
leptospirosis renal disease by mediating the activation of the
nuclear factor-kB-associated pathways and the release of
cytokines.6,7 Werts et al.18 have provided the first demonstra-
tion that TLR2 is required for the activation of macrophages
by leptospiral outer membrane constituents. Because this
TLR is highly expressed in renal tubule cells, the question
arises as to whether TLR2 participates in the inflammatory
response triggered by pathogenic leptospires in renal
proximal epithelial tubule cells. To answer this question,
experiments were carried out to analyze the expression of
TLR2 stimulated by leptospiral OMPs and its participation in
the induction of the inflammatory response caused by
pathogenic leptospiral OMPs in cultured mouse proximal
tubule PKSV-PR cells19 and in human embryonic kidney
(HEK) 293 cells transiently expressing TLR2. The results of
this study indicate that OMPs from pathogenic leptospires
and purified LipL32 increased the expression of TLR2 and
stimulated the release of the monocyte chemoattractant
protein-1 (CCL2/MCP-1) in renal proximal tubule cells.
These results strongly suggest thus that TLR2 initiate the
inflammatory response caused by pathogenic leptospires in
renal tubule epithelial cells.
RESULTS
Pathogenic leptospiral OMP extract stimulates the
expression of TLR2 in cultured late proximal tubule cells
We first analyzed the effects of leptospiral OMPs on TLR2
and TLR4 expression in cultured mouse PKSV-PR cells by
using flow cytometry. Adding 0.2 mg/ml OMPs extracted
from Leptospira santarosai serovar Shermani for 48 h
increased TLR2 expression by 28% as compared to untreated
cells (Po0.05). In contrast, the stimulation by leptospiral
OMPs did not induce any increase in the expression of TLR4
(Figure 1a). Consistent with these results, indirect immuno-
fluorescence studies revealed that leptospiral OMPs induced a
marked redistribution of the cytoplasmic TLR2 at the cell
peripheries of proximal tubule cells, without affecting the
weak cytoplasmic TLR4 staining (Figure 1b).
The levels of mRNA expression for TLR2, TLR4, and
b-actin were then analyzed by using reverse transcriptase
(RT)-competitive polymerase chain reaction (PCR). Incuba-
tion of PKSV-PR cells with 0.2, 0.3, 0.5, or 1 mg/ml leptospiral
OMPs for 48 h induced significant 1.8-, 1.8-, 1.9-, and 1.8-
fold increase, respectively, in the level of TLR2/b-actin mRNA
expression as compared to that of untreated cells. Conversely,
no changes in TLR4/b-actin mRNA levels were observed
when incubating cells with increasing concentrations of
leptospiral OMPs (Figure 2a). The levels of TLR2 and b-actin
mRNA expression were further analyzed with the two
recombinant LipL32 and LipL41 leptospiral lipoproteins.
Incubating cells with increasing concentrations (0.6–12 ng/ml)
of LipL32 for 48 h induced significant 1.5- to 1.9-fold
increases in the level of TLR2/b-actin mRNA expression as
compared to that of untreated cells. Conversely, no changes
in TLR2/b-actin mRNA levels were observed when incubat-
ing cells with increasing concentrations of recombinant
LipL41 (Figure 2b).
To ensure that the observed increase in TLR2 expression
was directly related to pathogenic leptospiral OMPs, addi-
tional experiments were carried out using OMPs extract from
another pathogenic serovar Leptospira interrogans serovar
Bratislava, and compared to that from the non-pathogenic
serovar Leptospira biflexa serovar Patoc. PKSV-PR cells were
incubated with these different OMPs extracts (0.2 mg/ml) for
48 h. The results from RT competitive-PCR revealed that
both OMPs extracted from L. santarosai serovar Shermani
and L. interrogans serovar Bratislava induced significant
(Po0.05) 1.8- and 1.6-fold increases, respectively, in the level
of TLR2/b-actin mRNA, whereas OMPs from L. biflexa
serovar Patoc did not affect the levels (Figure 3a). Overall
these results suggested that leptospiral OMPs activate the
innate immune receptor TLR2 in renal proximal tubule cells.
Effects of recombinant LipL32 and antibody raised against
LipL32 on TLR2 expression in late proximal tubule cells
To answer whether LipL32, a major component of pathogenic
leptospires, could per se stimulate the expression of TLR2 in
renal proximal tubule cells, cultured PKSV-PR cells were
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Figure 1 | Effects of leptospiral outer membrane proteins on TLR2
and TLR4 expression in renal proximal tubule cells. (a) Flow
cytometry analysis of mouse proximal tubule cells stimulated with
leptospiral OMP extracts. TLR2 and TLR4 fluorescence-activated cell
sorting analyses using monoclonal rat anti-mouse TLR2 antibody,
monoclonal rat anti-mouse TLR4 antibody or rat immunoglobulin
G2a isotype as control were performed on confluent PKSV-PR cells
incubated with or without 0.2 mg/ml L. santarosai serovar Shermani
OMPs for 48 h. Note the increase in TLR2 fluorescence signal
following the addition of leptospiral OMPs (a) while the profile of
TLR4 fluorescence did not change in leptospiral OMPs-treated cells.
(b–g) Immunodetection of TLR2 in PKSV-PR cells. Immunofluores-
cence studies using anti-TLR2 and TLR4 antibodies were performed
on confluent PKSV-PR cells incubated (c, f) without or (d, g) with
0.2mg/ml L. santarosai serovar Shermani OMPs for 48 h. Note the
marked TLR2 staining delineating cell peripheries in (d) leptospira-
treated cells as compared to that of (c) untreated cells. (f, g) In
contrast, leptospiral OMPs did not affect the TLR 4 staining. As
controls, only a faint labeling was observed by using (b) preimmune
rabbit serum or (e) rat isotype immunoglobulin G control. Original
magnification:  1000.
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therefore incubated with the recombinant LipL32 alone or
with antisera raised against LipL32 (anti-LipL32). The
recombinant LipL32 (2.4 ng/ml for 48 h) stimulated by
2.7-fold the level of TLR2 mRNA expression in confluent
cultures of PKSV-PR cells. Co-incubation of the cells with
recombinant LipL32 and the anti-LipL32 antibody partially
prevented the increase in TLR2 expression: the anti-LipL32
antibody significantly reduced (Po0.05) by 50% the
expression of TLR2 mRNA (Figure 3b). As control,
replacement of the anti-LipL32 antibody by preimmune
serum had almost no effect on the induction of TLR2 mRNA
expression induced by LipL32. Altogether, these results
indicate that LipL32 can directly affect TLR2 gene expression
in renal proximal tubule cells.
Role of TLR2 in iNOS and CCL2/MCP-1 stimulation caused by
leptospiral OMPs or LipL32
Adding L. santarosai serovar Shermani OMPs (0.2 mg/ml for
48 h) to cultured PKSV-PR cells significantly increased the
expression of inducible nitric oxide synthase (iNOS) ( 6.3-
fold, Po0.01) and CCL2/MCP-1 ( 2.8-fold, Po0.05) mRNAs
as compared to those measured in untreated cells. PKSV-PR
cells were further incubated with L. santarosai serovar
Shermani OMPs alone or with antisera raised against TLR2
and/or TLR4 (gifts from Tularik Inc., San Francisco,
CA, USA) to evaluate the respective roles of TLR2 and
TLR4. Preincubation of the cells with the anti-TLR2
antibody significantly reduced (Po0.05) by 46 and 69%
the increase in iNOS and CCL2/MCP-1 mRNAs, respectively,
caused by leptospiral OMPs. On the other hand, the
anti-TLR4 antibody did not significantly reduce the levels
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Figure 3 | Effects of pathogenic and non-pathogenic leptospiral
OMP and purified LipL32 on TLR2 expression in renal proximal
tubule cells. (a) Effects of outer membrane protein extracts from
pathogenic L. santarosai serovar Shermani, L. interrogans serovar
Bratislava and non-pathogenic serovar L. biflexa serovar Patoc on
TLR2 mRNA expression in renal proximal tubule cells. b-Actin was
used as internal standard. PKSV-PR cells were incubated with
0.2mg/ml of different OMPs extracts for 48 h. The results from RT-
competitive PCR and were expressed as TLR2/b-actin mRNA ratio and
the percent changes of untreated cell values (control, C). (b) Effects of
LipL32 on TLR2 expression in proximal tubule cells. PKSV-PR cells
were incubated with recombinant LipL32 alone or with LipL32 plus
an antiserum raised against LipL32 (anti-LipL32) or with a preimmune
serum (PIS). Note that the recombinant LipL32 increased the
expression of TLR2 and that the anti-LipL32 antibody blunted the
increase in TLR2 expression caused by LipL32. M: marker; C: control;
LS: Leptospira santarosai serovar Shermani; LB: Leptospira interrogans
serovar Bratislava; LP: Leptospira biflexa serovar Patoc. The bars are
means7s.e.m. from three independent experiments. *Po0.05 versus
control untreated (C).
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Figure 2 | Effects of increasing concentrations of leptospiral
OMPs, LipL32, and LipL41 on the expression of TLR2 and TLR4
mRNAs. PKSV-PR cells were incubated with increasing concentra-
tions of purified OMPs extracted from (a) L. santarosai serovar
Shermani or (b) increasing concentrations of LipL32 or LipL41 for
48 h. The results from RT-competitive RT-PCR were expressed as
percent changes of (c) untreated control cell values and corrected by
the values of b-actin mRNA, used as internal standard. M: marker;
C: control. The bars are the means7s.e.m. from three independent
experiments. *Po0.05 versus control untreated (C).
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of iNOS and CCL2/MCP-1 stimulated by leptospiral OMPs.
Furthermore, preincubating cells with the anti-TLR4 anti-
body plus the anti-TLR2 antibody did not further reduce the
increased levels of iNOS and CCL2/MCP-1 mRNAs
caused by leptospiral OMPs. These findings indicate thus
that TLR2, but not TLR4, is specifically involved in the
induction of iNOS and CCL2/MCP-1 caused by leptospiral
OMPs (Figure 4a).
Cultured renal proximal tubule cells were then further
incubated with the recombinant LipL32 (2.4 ng/ml) and the
anti-TLR2 antiserum. Recombinant LipL32 significantly
increased the mRNA levels of iNOS by 2.0-fold (Po0.05)
and CCL2/MCP-1 by 1.7-fold (Po0.05), respectively. In
contrast, preincubation of the cells with the anti-TLR2
antiserum prevented (Po0.05) the increase in iNOS and
CCL2/MCP-1 caused by LipL32 by 52 and 35%, respectively.
Again, the replacement of the anti-TLR2 antibody by the
preimmune serum had almost no inhibitory action on
LipL32-stimulated iNOS or CCL2/MCP-1 expressions (Fig-
ure 4b). These results strongly suggest that TLR2 mediates
the induction of tubulointerstitial nephritis-related mRNAs
caused by leptospiral OMPs or LipL32.
Time course of leptospiral OMPs induced TLR2 and
CCL2/MCP-1 expression in proximal tubule cells
Confluent PKSV-PR cells grown in serum-free medium for
24 h were then incubated with leptospiral OMPs (0.2 mg/ml)
for various periods. Expression of TLR2, CCL2/MCP-1, and
b-actin mRNAs was analyzed by competitive RT-PCR as a
function of time. The TLR2 mRNA was activated within 2 h
of stimulation followed by the increase of CCL2/MCP-1
mRNA and a progressive increase of CCL2/MCP-1 secreted
protein measured by enzyme-linked immunosorbent assay
(ELISA) in the culture supernatant (Figure 5).
Effects of leptospiral OMPs on CCL2/MCP-1 in TLR2- and
TLR4-transfected HEK 293 cells
To further assess the role of TLR2 in the induction of CCL2/
MCP-1 caused by leptospiral OMPs, HEK 293 cells normally
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Figure 4 | Effects of L. santarosai serovar Shermani OMPs or
LipL32 and antibody raised against TLR2 or TLR4 on iNOS and
CCL2/MCP-1 mRNA expression in proximal tubule cells. b-Actin
was used as internal standard. (a) Dissociated effects of TLR2 and
TLR4 on the induction of iNOS and CCL2/MCP-1 mRNA expression
caused by leptospiral OMPs in proximal tubule cells. b-Actin was used
as internal standard. PKSV-PR cells were incubated with L. santarosai
serovar Shermani OMPs (LS) alone (0.2 mg/ml for 48 h), LS plus an
antibody directed against TLR2 or TLR4, LS plus the two TLR2 and
TLR4 antibodies or LS plus a preimmune serum (PIS). (b) PKSV-PR cells
were incubated or not with LipL32 alone, LipL32 plus the anti-TLR2
antibody or LipL32 plus a preimmune serum (PIS). Note that in both
cases the blocking anti-TLR2 antibody prevented the rise in iNOS and
CCL2/MCP-1 mRNA expression induced by LS or LipL32 and that PIS
had no effect. The bars are means7s.e.m. from three independent
experiments. M: marker; C: control. *Po0.05; **Po0.01 versus control
untreated (C).
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Figure 5 | Time course of leptospiral OMPs induced TLR2 and
CCL2/MCP-1 expression in proximal tubule cells. Confluent PKSV-
PR cells grown in serum-free medium for 24 h were then incubated
with leptospiral OMPs (0.2 mg/ml) for various periods. Expression of
TLR2, CCL2/MCP-1, and b-actin mRNAs was analyzed by competitive
RT-PCR as a function of time. As a control, b-actin was utilized as the
internal standard. The secretion of CCL2/MCP-1 recovered in culture
supernatants from PKSV-PR cells stimulated for various periods was
measured by ELISA. The TLR2 mRNA was activated within 2 h of
stimulation followed by the increase of CCL2/MCP-1 mRNA and a
progressive increase of CCL2/MCP-1 secreted protein in the cultures
supernatant. Values are means7s.e.m. of duplicate measurements
from three independent experiments. In all cases, values were
significantly higher (**Po0.01; *Po0.05) than those of untreated cells
(time, 0).
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lacking TLR2 and TLR4 were transiently transfected with
TLR-expressing plasmids. We first checked that HEK 293 cells
transfected with an empty vector do not express TLR2 or
TLR4. In contrast, strong TLR2 or TLR4 mRNA expressions
were detected in TLR2- or TLR4-transfected cells, respec-
tively. Interestingly, leptospiral OMPs only increased the
expression of CCL2/MCP-1 mRNA levels in TLR2-trans-
fected cells but not in TLR4-transfected cells or in empty
vector-transfected cells (Figure 6a and b).
Additional experiments were then carried out on HEK 293
cells transiently transfected with TLR2- or TLR4-expressing
plasmids or with both plasmids and incubated with two
concentrations (0.2 and 0.4 mg/ml) of leptospiral OMPs. In
both cases, OMPs significantly increased (Po0.05) the
CCL2/MCP-1 mRNA expression by 3.1- to 3.4-fold, respec-
tively (Figure 7a). Consistent with these results, 0.2 and
0.4 mg/ml OMPs also significantly increased by 1.9- and 2.1-
fold, respectively, the secretion of the CCL2/MCP-1 protein
recovered in medium supernatants from HEK 293 cells
transfected with the TLR2-expressing plasmid (Figure 7b).
Conversely, HEK 293 cells transfected with the TLR4-
expressing plasmid remained unresponsive to leptospiral
OMPs. Additionally, double transfection of TLR2 and TLR4-
expressing plasmids did not result in further increase in
CCL2/MCP-1 expression (mRNA and protein) as compared
to that achieved with the TLR2-expressing plasmid alone
(Figure 7a and b). Thus, these experiments provide
additional evidence that the innate immunity TLR2 pathway
mediates the induction of CCL2/MCP-1 caused by patho-
genic leptospiral OMPs in proximal tubule epithelial cells.
DISCUSSION
The results of this study provide lines of evidence that TLR2
mediates the early inflammatory response caused by
pathogenic leptospires in renal proximal tubule cells. At least
11 TLRs have been identified so far in immune cells and in a
variety of epithelial cells.20–23 Renal tubule epithelial cells are
among the non-immune cells that express TLR1, TLR-2,
TLR-3, TLR-4, and TLR-6;12,24 TLR2 and TLR-4, the main
receptors of Gram-positive and -negative bacteria,25,26 are
constitutively expressed in both proximal and distal tubular
renal epithelial cells in vivo.27 Renal inflammation caused by
warm ischemia–reperfusion was shown to cause a marked
increase in TLR2 and -4 mRNA synthesis dependent on the
action of tumor necrosis factor-a and interferon-g.12 In the
kidney, TLR4 is required for the resistance to Gram-negative
bacteria, as assessed by the persistence of Gram-negative
bacteria in experimental models of pyelonephritis induced in
C3H/HeJ mice harboring a non-functional TLR4, when
compared to the rapid renal clearance of bacteria in wild-type
counterparts.28 TLR2 has a broader specificity, as it
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Figure 7 | Effects of various concentrations of L. santarosai
serovar Shermani OMPs in TLR2- and TLR4-expressing HEK 293
cells. HEK293 cells were transfected with TLR2 or TLR4 alone or in
combination. (a) Results from RT-competitive PCR for CCL2/MCP-1
and b-actin, used as internal standard. Note that only 0.2 and 0.4mg/ml
leptospiral OMPs stimulated the expression of CCL2/MCP-1 mRNA
in TLR2-expressing HEK 293 cells. (b) The bars represent the
quantitative results for the levels of CCL2/MCP-1 mRNA and the
amount of CCL2/MCP-1 protein recovered in supernatants. Note that
TLR2-expressing HEK 293 cells responded to 0.2 and 0.4 mg/ml
leptospiral OMP with increased expression of CCL2/MCP-1 mRNA and
protein, and that TLR4-expressing HEK 293 cells remain unresponsive.
Double transfection of TLR2 and TLR4 did not cause further increase
in CCL2/MCP-1 expressions as compared to that of single TLR2
transfection. The bars are means7s.e.m. from four independent
experiments. C: control; LS: Leptospira santarosai serovar Shermani.
*Po0.05 versus control untreated.
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Figure 6 | Effects of transient expression of TLR2 or TLR4 in HEK
293 cells. (a) TLR2 and CCL2/MCP-1 mRNA expression was measured
in HEK 293 cells transiently transfected with a TLR2-expressing
plasmid. b-Actin was used as internal standard (a, upper panel). As
control, no TLR2 mRNA was detected in HEK 293 cells transfected
with an empty vector Transfected HEK 293 cells were then incubated
or not with leptospiral OMPs (0.2 mg/ml) for 48 h. Thereafter, CCL2/
MCP-1 mRNA expression was found increased in the TLR2-transfected
cells. (b) In HEK 293 cells transfected with TLR4-expressing plasmid,
LS stimulated did not affect CCL2/MCP-1 mRNA expression in TLR4-
expressing HEK 293 cells. The bars are means7s.e.m. from four
independent experiments. C: control; LS: Leptospira santarosai
serovar Shermani. *Po0.05; **Po0.01 versus control untreated (C).
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recognizes microbial components from bacteria, mycobacter-
ia, mycoplasma, and also spirochetes. Werts et al.18 have
demonstrated that the activation of macrophages by
leptospiral LPS requires CD14 and TLR2. The components
of the leptospiral outer membrane certainly determine the
virulence of pathogenic leptospires. Many of the most
abundant proteins in the spirochetal outer membrane are
lipoproteins that participate in the pathogenesis of tubu-
lointerstitial nephritis.8,29 Previous studies have shown that
the leptospiral outer membrane has a relatively complex
protein profile.30–32 Outer membrane antigenic proteins
along with leptospiral LPS are expressed in infected kidneys,8
suggesting their roles in the induction and persistence of
leptospirosis tubulointerstitial nephritis. The OMP extraction
method used in this study enhanced the harvest of
lipoprotein components. Although one cannot exclude a
role for contaminant leptospiral LPS in OMPs preparations,
it remains that glycolipoprotein are responsible for major
leptospiral toxicity.33 In this line, we had previously shown
that heat and proteinase K digestion of leptospiral OMP
extracts significantly reduced their inducible action on iNOS
and CCL2/MCP-1 expressions in renal tubule cells.6 More-
over, polymyxin B, which inhibits the LPS activity, did no
significantly impair the inducible action of leptospiral OMPs
(data not shown). To further rule out any participation of
contaminant LPS from Escherichia coli preparations in
experiments using LipL32 and LipL41, the recombinant
lipoproteins were treated with endotoxin-removing gel.
LipL32, but not LipL41, stimulated in a dose-dependent
manner the expression of TLR2 mRNA in proximal tubule
cells. These results are in agreement with a previous study,
which showed that LipL41 did not stimulate iNOS or CCL2/
MCP-1 expression in proximal tubule cells.7 Overall, these
results strongly suggest that LipL32 represents the main
leptospiral outer membrane lipoprotein responsible for the
induction of the proinflammatory response in renal tubule
cells. Here, we also show that the neutralizing anti-TLR2
antibody used, but not the anti-TLR4 antibody, inhibits the
inducible action of leptospiral OMPs on the iNOS and CCL2/
MCP-1 downstream products. The results from TLR
transfection studies also provide additional evidence that
TLR2 is the innate receptor for leptospiral OMPs in renal
proximal tubule cells. In HEK 293 cells that do not express
TLRs, the transient expression of TLR2 allows leptospiral
OMPs to increase the expression levels of CCL2/MCP-1. In
contrast, no stimulation of CCL2/MCP-1 could be detected
in TLR4-transfected HEK 293 cells. Thus, these results
strongly suggest that TLR2 mediates the induction of the
inflammatory response of renal epithelial cells caused by
pathogenic leptospires. This is the first demonstration that
pathogenic leptospires, which specifically invade and reside
in the kidney, may trigger an innate immune response
through TLR2-dependent pathway in proximal tubule cells.
Chemotactic chemokines responsible for the recruitment
of leukocytes to the site of inflammation are upregulated in a
variety of glomerular and interstitial renal injuries.34,35 We
have previously shown that leptospiral OMPs and LipL32
stimulate the expression of CCL2/MCP-1 and RANTES
(regulated upon activation normal T-cell expressed and
secreted) in association with increased generation of iNOS
and tumor necrosis factor-a.6,7 These findings have revealed
that leptospiral OMPs are able to provoke an inflammatory
response in injured renal tubule cells and thereby permit the
recruitment of infiltrating cells into the renal interstitium.6,7
Recent studies have also shown that the expression of TLR2
in human HEK 293 cells mediates the activation of nuclear
factor-kB and enables stress-activated mitogen-activated
protein kinase p38 phosphorylation in response to LPS,
membrane lipoproteins or Gram-positive bacterial pro-
ducts.36 In accordance with these findings, we found that
leptospiral OMPs stimulate the phosphorylated mitogen-
activated protein kinase p38 in proximal tubule cells
(manuscript in preparation). Together with the present
findings, these results therefore support the hypothesis that
pathogenic leptospiral OMPs conceivably initiate tubuloin-
terstitial nephritis through the components contained in the
outer membrane that binds to TLR2 in proximal tubule cells.
The present results also show that TLR4 may not be required
in the recognition of leptospiral OMPs. These results are in
accordance with previous studies which showed that the LPS
isolated from L. interrogans as well as LipL32 stimulate the
production of IL-8 and tumor necrosis factor-a in human
macrophages via a TLR2-mediated pathway, and that TLR2-
deficient mice are insensitive to leptospiral LPS.18 Koizumi
et al.37 have also shown that TLR4-deficient C3H/HeJ mice
remain sensitive to leptospiral infection, suggesting that
TLR4 is not a major mediator in leptospirosis infection.
Consistent with these studies, the present work provides
additional evidence that TLR2 represents the main pattern
recognition receptor recognizing pathogenic leptospiral
OMPs. In conclusion, the present findings provide a basis
for understanding the molecular mechanisms controlling the
innate immune response caused by leptospirosis in renal
tubule cells, which will serve for future studies devoted to the
understanding of the pathogenesis of microorganism-in-
duced tubulointerstitial nephritis.
MATERIALS AND METHODS
Preparation of OMPs extract of leptospires
Two frequently encountered pathogenic leptospires serovar
L. santarosai serovar Shermani (ATCC number 43286TM) and
L. interrogans serovar Bratislava (ATCC number 23578TM), and a
non-pathogenic L. biflexa serovar Patoc (ATCC number 23582TM),
were obtained from ATCC (Rockville, MD, USA) and grown in 10%
Ellinghausen McCullough Johnson Harris leptospiral enrichment
medium (Difco, Detroit, MI, USA). The OMPs were extracted with
1% Triton X-114 and more than 90% of OMPs were extracted in the
Triton X-114 detergent phase.6
Cloning LipL32 and LipL41
Standard recombinant DNA procedures were undertaken to clone
LipL32 and LipL41 as described.7 LipL32, but not LipL41, can
induce a robust inflammatory response in cultured mouse proximal
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tubule cells.7 Thus, LipL41 was used to compare the effect of LipL32
in TLR activation. The recombinant proteins were passed through
an endotoxin-removing gel, Detoxigel (Pierce Biotechnology Inc.,
Rockford, IL, USA), to remove possible contamination by LPS, and
controlled by the Limulus Amebocyte Lysate assay.
Cultured proximal tubule cells
The PKSV-PR cells employed herein were derived from isolated late
proximal tubules (PR) dissected from the kidney of an L-PK/Tag1
transgenic mouse as specified earlier.19 Experiments were under-
taken on exponentially growing or confluent cells between the 40
and 55th passages. Cells were shifted to a serum-free medium 24 h
before adding OMP extract or recombinant lipoproteins to the cell
culture medium for 48 h. Total RNA was extracted to undergo
RT-PCR, and supernatant was collected to measure the amounts of
protein. All measurements were made at least in triplicate.
Flow cytometry
PKSV-PR cells (1 106/ml) were incubated or not with leptospiral
OMPs for 48 h. After washing, 2 105 cells were resuspended in
200ml phosphate-buffered saline containing 1% bovine serum
albumin and 0.01% sodium azide. The cells were preincubated with
1 mg/ml of Fc block (BD PharMingen, San Diego, CA, USA) before
incubating them with a monoclonal rat anti-mouse TLR2 antibody
or a monoclonal rat anti-mouse TLR4 antibody (eBioscience, San
Diego, CA, USA). Similar experiments were performed using a rat
immunoglobulin G2a isotype control antibody. Cells were washed
and incubated with a fluorescein isothiocyanate-labeled anti-rat
immunoglobulin G antibody and analyzed using a FACS Calibur
System (Becton, Dickinson and Company, Franklin Lakes, NJ, USA)
flow cytometer. The data were analyzed using Win MDI 2.8
software.
Immunofluorescence studies
Confluent cultures of PKSV-PR cells incubated or not with
leptospiral OMP were first incubated with rabbit anti-mouse
TLR2 or rat monoclonal anti-mouse TLR4 antibodies (eBioscience,
San Diego, CA, USA) followed by fluorescein isothiocyanate species-
specific secondary antibodies and were examined using an inverted
microscope equipped with epifluorescence optics.
Competitive RT-PCR assay
RNA was extracted from confluent proximal tubule cells using RNA-
zol (Cinna/Biotecx Laboratories International Inc., Friendwood, TX,
USA) and was reverse transcribed as described.6 The sets of iNOS,
CCL2/MCP-1, and b-actin primers used for RT-PCR were the same
as described previously.38,39 The mouse TLR2 primer pair was
50-GTG CCA CCA TTT CCA CGG GC-30(sense) and 50-CAA AAC
ACT TCC TGC TGG CC-30 (antisense), yielding a 501 bp PCR
product. The mouse TLR4 primer pair was 50-AGT GGG TCA AGG
AAC AGA AGC A-30(sense) and 50-CTT TAC CAG CTC ATT TCT
CAC C-30 (antisense), yielding a 311 bp PCR product. PCR primers
were also used to detect human cDNA in HEK 293 cells. The human
TLR2 primer pair was 50-GCC AAA GCT TTG ATT GAT TGG-30
(sense) and 50-TTG AAG TTC TCC AGC TCC TG-30 (antisense),
yielding a 347 bp PCR product. The human TLR4 primer pair was
50-TGC GGG TTC TAC ATC AAA-30(sense) and 50-CCA TCC GAA
ATT ATA AGA AAA GTC-30 (antisense), yielding a 413 bp PCR
product. The human CCL2/MCP-1 primer pair was 50-CCT GCT
GTT ATA ACT TCA CC-30(sense) and 50-ACA TCC CAG GGG TAG
AAC TG-30 (antisense), yielding a 450 bp PCR product. The human
b-actin primer pair was 50-CCC CAG GCA CCA GGG CGT GAT-30
(sense) and 50-GGT CAT CTT CTC GCG GTT GGC CTT GGG
GTT-30 (antisense), yielding a 263 bp PCR product. The PCR
products were analyzed initially by amplifying at the exponential
phase. Competitive PCR assays were performed to evaluate the
mRNA levels and the mean values of each measured mRNA/b-actin
ratio were further expressed as a percentage change of the control
values in each experiment.40,41 Competitive PCR was performed to
measure mouse TLR2, CCL2/MCP-1, iNOS, b-actin, and for human
CCL2/MCP-1, b-actin, using deletion cDNA mutant.
Enzyme-linked immunosorbent assay
HEK 293 cells were incubated without or with L. santarosai serovar
Shermani OMPs and the CCL2/MCP-1 protein recovered in culture
medium was measured by ELISA using the commercially available
kit Quantikine (R&D systems, Minneapolis, MN, USA).
LipL32 antisera
Antiserum to LipL32 was prepared by immunizing New Zealand
White rabbits with purified His6-LipL32 fusion proteins. These
proteins were expressed by E. coli BL21 (DE3) pLysS transformed
with the pRSET plasmid that contained the LipL32 gene as described
previously.7
Transient transfection of TLR in HEK 293 cells
The pUNO-hTLR2, pDUO-MD2/TLR4, and pUNO empty plasmids
were obtained from InvivoGen Inc. (San Diego, CA, USA). The HEK
293 cells (ATCC, Manassas, VA, USA) were plated into six-well
tissue culture plates and maintained in Dulbecco’s minimum
essential medium supplemented with 10% FCS. Cells were
transfected using the LipofectamineTM 2000 transfection protocol
(Life Technologies Inc., Carlsbad, CA, USA) with 4.0mg pUNO,
pUNO-hTLR2 or/and pDUO-MD2/TLR4, and 6.0 ml Lipofectamine.
Transfected cells were selected in medium containing 10 mg/ml
blasticidin S (InvivoGen, San Diego, CA, USA) and maintained in
1–3mg/ml blasticidin S-supplemented medium. Transfected cells
were cultured in normal medium for 36–48 h, and then in serum-
free medium for additional 18 h before adding leptospiral OMPs for
24 h. Total mRNA was then extracted for RT-PCR and supernatants
were tested for CCL2/MCP-1 by ELISA. All of the transfection
experiments were repeated at least twice.
Statistical analysis
All measurements were made at least in triplicate and the results
were expressed as means7s.e.m. Differences among groups were
analyzed by the unpaired Student’s t-test or analysis of variance
when appropriate. A Po0.05 was considered significant.
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